肉瘤的3D模型:个性化医疗的下一代工具。
3D Models of Sarcomas: The Next-generation Tool for Personalized Medicine.
作者信息
Xu Ruiling, Chen Ruiqi, Tu Chao, Gong Xiaofeng, Liu Zhongyue, Mei Lin, Ren Xiaolei, Li Zhihong
机构信息
Department of Orthopaedics, The Second Xiangya Hospital, Central South University, No. 139 Renmin Road, Changsha, 410011 Hunan China.
Hunan Key Laboratory of Tumor Models and Individualized Medicine, No. 139 Renmin Road, Changsha, 410011 Hunan China.
出版信息
Phenomics. 2023 Oct 4;4(2):171-186. doi: 10.1007/s43657-023-00111-3. eCollection 2024 Apr.
Sarcoma is a complex and heterogeneous cancer that has been difficult to study in vitro. While two-dimensional (2D) cell cultures and mouse models have been the dominant research tools, three-dimensional (3D) culture systems such as organoids have emerged as promising alternatives. In this review, we discuss recent developments in sarcoma organoid culture, with a focus on their potential as tools for drug screening and biobanking. We also highlight the ways in which sarcoma organoids have been used to investigate the mechanisms of gene regulation, drug resistance, metastasis, and immune interactions. Sarcoma organoids have shown to retain characteristics of in vivo biology within an in vitro system, making them a more representative model for sarcoma research. Our review suggests that sarcoma organoids offer a potential path forward for translational research in this field and may provide a platform for developing personalized therapies for sarcoma patients.
肉瘤是一种复杂且异质性的癌症,一直难以在体外进行研究。虽然二维(2D)细胞培养和小鼠模型一直是主要的研究工具,但三维(3D)培养系统,如类器官,已成为有前景的替代方法。在本综述中,我们讨论了肉瘤类器官培养的最新进展,重点关注其作为药物筛选和生物样本库工具的潜力。我们还强调了肉瘤类器官用于研究基因调控、耐药性、转移和免疫相互作用机制的方式。肉瘤类器官已显示在体外系统中保留体内生物学特征,使其成为肉瘤研究更具代表性的模型。我们的综述表明,肉瘤类器官为该领域的转化研究提供了一条潜在的前进道路,并可能为开发针对肉瘤患者的个性化疗法提供一个平台。
相似文献
Phenomics. 2023-10-4
Int J Mol Sci. 2018-2-21
Exp Biol Med (Maywood). 2022-12
Biomed Pharmacother. 2022-5
Hum Reprod Update. 2018-3-1
Front Cell Dev Biol. 2023-1-9
Biochemistry (Mosc). 2024-1
引用本文的文献
Invest Ophthalmol Vis Sci. 2025-6-2
Bioengineering (Basel). 2025-3-8
NPJ Precis Oncol. 2025-2-9
本文引用的文献
EMBO Mol Med. 2022-10-10
J Gastroenterol Hepatol. 2022-8
Bioinformatics. 2022-5-13
Sci Adv. 2022-2-18